. . . . . . . . "PRIALT (ziconotide) solution, intrathecal infusion is indicated for the management of severe chronic pain in adult patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine" . . . "NeuroDKG" . . . "adult patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine" . "18" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "dNUDeag4QuIhj20K/O/qc/ZEfRtAIheMDcH3xAnCCkjEpvQMgZ47uoWN2xQjV6vylBDCzdMwo4bIiORrY2TIHzENNzkLFm/Kxe/hGap1+4c5pIN+AcH5W3YtJK3yYcbOaCCM3BTGnPwQfkgWAZV4K2oXaiEbZa9BuPNyP+WRQtQ=" . . "2021-03-28T19:00:44.352+02:00"^^ . . . . .